在AA氨基粉症患者中使用生物疗法,接受透析-A系统性文献审查
Ege Sinan Torun1, Gülay Kadıoğlu2
1Department of Internal Medicine, Division of Rheumatology, University of Health Sciences, Prof. Dr. Cemil Taşçıoğlu City Hospital, Istanbul, Turkey.
概括
生物制剂在透析患者中有效控制AA氨基粉症,尽管存在感染风险,但仍有好处. 这一系统性审查强调了他们在置换治疗期间管理这种渐进性疾病的潜力.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 类风湿病学 类风湿病学
- 免疫学 免疫学 免疫学
背景情况:
- 生物药物为AA氨基粉症提供了治疗选择.
- 由于感染问题,透析患者停止使用生物制剂是常见的.
- 在透析患者中,AA氨基粉症的进展对额外的器官构成风险.
研究的目的:
- 评估在接受透析的AA氨基粉症患者中生物制剂的益处和风险.
主要方法:
- 在Cochrane数据库和MEDLINE进行的系统文献审查.
- 专注于在AA氨基粉症透析患者中使用生物制剂.
主要成果:
- 分析了22项研究中的55名患者.
- 在94.5%的患者中,生物药物实现了初级疾病控制.
- 最常见的副作用包括感染;死亡发生在8名患者中.
结论:
- 生物药物在接受透析的AA氨基粉症患者中显示出有效性.
- 在这种患者群体中,生物制剂的安全性似乎是可以接受的.
相关概念视频
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis
1.1K
Patients with end-stage renal disease (ESRD) or those experiencing drug overdose often require extracorporeal methods to eliminate accumulated drugs and metabolites. Hemoperfusion, hemofiltration, and dialysis are the primary techniques to rapidly remove harmful substances without disrupting the patient's fluid and electrolyte balance. For those with compromised renal function, dosage adjustments of concurrent medications may be necessary during extracorporeal drug removal.Dialysis is a process...
1.1K
Hemodialysis I: Introduction
4.0K
Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
4.0K
Hemodialysis II: Procedure and Complications
2.2K
DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
2.2K
Acute Kidney Injury IV: Diagnostic Studies and Prevention
559
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
559
Acute Kidney Injury V: Interprofessional Care
527
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
527
Chronic Kidney Disease III: Interprofessional Care
679
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
679


